Trial Profile
A Translational Study to Understand the Mechanism of Apolipoprotein CIII Reduction Via Colchicine
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Colchicine (Primary)
- Indications Hyperlipoproteinaemia; Hypertriglyceridaemia
- Focus Therapeutic Use
- 09 Jun 2014 New trial record